Vapor-Liquid Equilibrium (VLE) Prediction with NRTL & UNIFAC
VLE prediction tells us how a liquid mixture splits into vapor and liquid parts when heated — like knowing exactly which alcohol and water vapors rise off a boiling still.
⚠️ Why It Matters
📘 Definition
Vapor-liquid equilibrium (VLE) describes the thermodynamic state at which a multicomponent liquid phase coexists in equilibrium with its vapor phase at fixed temperature, pressure, and composition. Activity coefficient models such as NRTL (Non-Random Two-Liquid) and UNIFAC (UNIQUAC Functional-group Activity Coefficients) quantify non-ideal interactions to predict phase compositions and bubble/dew points. These models are foundational for rigorous simulation of separation processes in chemical process design.
🎨 Concept Diagram
AI-generated illustration for visual understanding
💡 Engineering Insight
Never trust a UNIFAC prediction without verifying the group assignment logic — misclassifying a 'carboxylic acid' as 'alcohol' changes Δgₘₙ by >150 J/mol and shifts azeotrope composition by ±0.15 mol-fraction. Always cross-check UNIFAC with NRTL fitted to at least one binary pair in your system.
📖 Detailed Explanation
NRTL excels when experimental binary VLE data exist — it fits τ and α to minimize objective functions like RMSD in y₁ or T. UNIFAC, by contrast, avoids fitting by decomposing molecules into functional groups (e.g., CH₃, OH, COOH) and using pre-regressed group–group interaction parameters. Its strength lies in predicting new mixtures, but accuracy drops sharply for associating fluids or electrolytes.
Advanced practice demands hybrid approaches: use UNIFAC to initialize NRTL regression, constrain αᵢⱼ within ±0.05 of literature values, and apply consistency tests (e.g., Van Ness area test) to ensure γᵢ data satisfy Gibbs–Duhem. For industrial applications involving trace impurities (<0.1 mol%), residual activity coefficient uncertainty must be propagated through column simulation to assess distillate specification risk — a step routinely omitted in early-stage design but critical for FDA-submitted pharmaceutical separations.
🔄 Engineering Workflow
📋 Decision Guide
| Rock/Field Condition | Recommended Design Action |
|---|---|
| Polar–nonpolar mixture (e.g., methanol–hexane), no binary data available | Use UNIFAC (Lyngby version, 2018 parameters); validate with batch distillation residue curve analysis |
| Strongly associated system (e.g., acetic acid–water) with high-boiling azeotrope | Prefer NRTL with temperature-dependent αᵢⱼ and ternary fit; avoid UNIFAC due to poor H-bond group representation |
| Hydrocarbon mixture (C₃–C₈) at near-ideal conditions (P < 10 bar, T < 150°C) | Use Wilson or simplified NRTL (αᵢⱼ = 0.3); UNIFAC overkill and introduces unnecessary uncertainty |
📊 Key Properties & Parameters
Activity Coefficient (γᵢ)
0.1–10.0 (unitless)Dimensionless factor quantifying deviation from Raoult’s law behavior for component i in a liquid mixture.
Directly determines relative volatility and thus minimum reflux ratio and theoretical stage requirements.
Binary Interaction Parameter (αᵢⱼ)
0.0–0.47 (unitless)Empirical parameter in NRTL representing non-randomness in local composition around component i and j.
Controls shape of activity coefficient curves; errors > ±0.05 cause >5% dew point error in ethanol–water systems.
Group Contribution Parameter (Δgₘₙ)
−200 to +300 J/molUNIFAC-specific interaction parameter between functional groups m and n, derived from experimental data.
Determines predictive accuracy for unseen mixtures; uncertainty > ±50 J/mol risks >10% vapor-phase mole fraction error in ketone–hydrocarbon systems.
Relative Volatility (αᵢⱼ)
1.05–50.0 (unitless)Ratio of effective volatilities of components i and j, αᵢⱼ = (yᵢ/xᵢ)/(yⱼ/xⱼ), where y = vapor mole fraction, x = liquid mole fraction.
Dictates feasibility of separation: α < 1.15 often requires extractive or azeotropic distillation.
📐 Key Formulas
NRTL Activity Coefficient
ln γᵢ = ∑ⱼ(xⱼτⱼᵢGⱼᵢ/∑ₖxₖGₖᵢ) + ∑ⱼ[xⱼ(Gᵢⱼ/∑ₖxₖGₖⱼ)(τᵢⱼ − ∑ₖxₖτₖⱼGₖⱼ/∑ₖxₖGₖⱼ)]Calculates component i activity coefficient using local composition and energy parameters.
| Symbol | Name | Unit | Description |
|---|---|---|---|
| γᵢ | Activity coefficient of component i | dimensionless | Measure of deviation from ideal solution behavior for component i |
| xⱼ | Mole fraction of component j | dimensionless | Mole fraction of component j in the liquid phase |
| τⱼᵢ | Energy parameter for pair j-i | dimensionless | Binary interaction parameter representing excess energy between components j and i |
| Gⱼᵢ | Margules energy parameter for pair j-i | dimensionless | Local composition parameter related to the energy parameter τⱼᵢ and non-ideality |
| τᵢⱼ | Energy parameter for pair i-j | dimensionless | Binary interaction parameter representing excess energy between components i and j |
| Gᵢⱼ | Margules energy parameter for pair i-j | dimensionless | Local composition parameter related to the energy parameter τᵢⱼ and non-ideality |
UNIFAC Group Contribution
ln γᵢ = ln γᵢᶜ + ln γᵢˢSplits activity coefficient into combinatorial (c) and residual (s) terms based on group surface area and interaction parameters.
| Symbol | Name | Unit | Description |
|---|---|---|---|
| γᵢ | Activity coefficient of component i | dimensionless | Measure of deviation from ideal solution behavior for component i |
| γᵢᶜ | Combinatorial contribution to activity coefficient of component i | dimensionless | Part of activity coefficient accounting for differences in molecular size and shape |
| γᵢˢ | Residual contribution to activity coefficient of component i | dimensionless | Part of activity coefficient accounting for energetic interactions between molecular groups |
🏭 Engineering Example
BASF Ludwigshafen Oleochemicals Plant
N/A — chemical process system🏗️ Applications
- Design of azeotropic distillation columns for ethanol dehydration
- Solvent selection for liquid–liquid extraction of APIs
- Predicting water content in compressed natural gas (CNG) dew point
🔧 Try It: Interactive Calculator
📋 Real Project Case
Pharmaceutical API Purification via Crystallization
Manufacture of high-purity ibuprofen API at FDA-compliant facility